Capacities of computer evaluation of hidden potential of phytochemicals of medicinal plants of the traditional Indian Ayurvedic medicine

  • A. A. Lagunin
  • D. S. Druzhilovsky
  • A. V. Rudik
  • D. A. Filimonov
  • D. Gawande
  • K. Suresh
  • R. Goel
  • V. V. Poroikov


Applicability of our computer programs PASS and PharmaExpert for prediction of biological activity spectra of rather complex and structurally diverse phytocomponents of medicinal plants, both separately and in combinations has been evaluated. For this purpose we have created the web-resource containing known information about structural formulas and biological activity of 1906 phytocomponents of 50 Ayurvedic medicinal plants used in Traditional Indian Medicine (TIM) ( The PASS training set was updated by addition of information about structure and biological activity of 946 natural compounds; then the training procedure and validation were performed, to estimate the quality of PASS prediction. It was shown that the differences between the average accuracy of prediction obtained in leave-5%-out cross-validation (94.467%) and in leave-one-out cross-validation (94.605%) are very small thus demonstrating high predictive ability of the program. Results of biological activity spectra prediction for all phytocomponents included in our database coincided in 83.5% of cases with known experimental data. Additional types of biological activity predicted with high probability indicate further promising directions for further studies of certain phytocomponents of some medicinal plants. The analysis of prediction results of sets of phytocomponents in each of 50 medicinal plants was made by the PharmaExpert software. Based on this analysis, we found that the combination of phytocomponents from Passiflora incarnata may exhibit nootropic, anticonvulsant, and antidepressant effects. Experiments carried out in mice models confirmed the predicted effects of P. incarnata extracts.


SAR PASS PharmaExpert computational prediction Ayurveda medicinal plants phytocomponents biological activity 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jorgensen, W.L., Science, 2004, vol. 303, pp. 1813–1818. doi 10.1126/science.1096361CrossRefGoogle Scholar
  2. 2.
    Ivanov, A.S., Veselovsky, A.V., Dubanov, A.V., and Skvortsov, V.S., in Methods in Molecular Biology vol. 116, Larson, E., Richard, S., Eds., Humana Press, 2006, pp. 389–431. doi 10.1385/1-59259-9648%3A389Google Scholar
  3. 3.
    Ivanov, A.S., Poroikov, V.V., and Archakov, A.I., Vestnik RGMU, 2003, no. 4, pp. 19–23.Google Scholar
  4. 4.
    Lagunin, A.A., Goel, R.K., Gawande, D.Y., Priynka, P., Gloriozova, T.A. Dmitriev, A.V., Ivanov, S.M., Rudik, A.V., Konova, V.I., Pogodin, P.V., Druzhilovsky, D.S., and Poroikov, V.V., Natural Product Reports, 2014, vol. 31, pp. 1585–1611. doi 10.1039/c4np00068dCrossRefGoogle Scholar
  5. 5.
    Archakov, A.I. and Ivanov, A.S., Vestnik RAMN, 1996, no. 1, pp. 60–63.Google Scholar
  6. 6.
    Medvedev, A.E., Ivanov, A.S., Veselovsky, A.V., Skvortsov, V.S., and Archakov, A.I., J. Chem. Inform. Comput. Sci., 1996, vol. 36, pp. 664–671. doi 10.1021/ci9802068CrossRefGoogle Scholar
  7. 7.
    Filimonov, D., Poroikov, V., Borodina, Yu., and Gloriozova, T., J. Chem. Inf. Comput. Sci., 1999, vol. 39, pp. 666–670. doi 10.1021/ci980335oCrossRefGoogle Scholar
  8. 8.
    Dubanov, A.V., Ivanov, A.S., and Archakov, A.I., Vopr. Med. Khim., 2001, vol. 47, pp. 353–367.Google Scholar
  9. 9.
    Veselovsky, A.V., Ivanov, Yu.D., Ivanov, A.S., Archakov, A.I., Lewi, P., and Janssen, P., J. Mol. Recognit., 2002, vol. 15, pp. 405–422. doi 10.1002/jmr.597CrossRefGoogle Scholar
  10. 10.
    Sobolev, B.N., Poroikov, V.V., Olenina, L.V., Kolesanova, E.F., and Archakov, A.I., Biomed. Khim., 2003, vol. 49, pp. 309–332.Google Scholar
  11. 11.
    Veselovsky, A.V., Ivanov, A.S., and Medvedev, A.E., Neurotoxicology, 2004, vol. 25, pp. 37–46. doi 10.1002/jmr.597CrossRefGoogle Scholar
  12. 12.
    Lagunin, A., Zakharov, A., Filimonov, D., and Poroikov, V., Molecular Informatics, 2011, vol. 30, pp. 241–250. doi 10.1002/minf.201000151CrossRefGoogle Scholar
  13. 13.
    Stulov, S.V., Mankevich, O.V., Novikov, R.A., Tkachev, Y.V., Timofeev, V.P., Dugin, N.O., Pozdnev, V.F., Fedyushkina, I.V., Scherbinin, D.S., Veselovsky, A.V., and Misharin, A.Y., Steroids, 2013, vol. 78, pp. 521–527. doi 10.1016/jsteroids.2013.02.014CrossRefGoogle Scholar
  14. 14.
    Ivanov, S.M., Lagunin, A.A., Zakharov, A.V., Filimonov, D.A., and Poroikov, V.V., Biomed. Khim., 2014, vol. 60, pp. 7–16.CrossRefGoogle Scholar
  15. 15.
    Filimonov, D.A., Poroikov, V.V., Karaicheva, E.I., Kazaryan, R.K., Budunova, A.P., Mikhailovskii, E.M., Rudnitskikh, A.V., Goncharenko, L.V., and Burov, Yu.V., Eksper. Klin. Farmakol., 1995, vol. 58, pp. 56–62.Google Scholar
  16. 16.
    Filimonov, D.A. and Poroikov, V.V., in Bioactive Compound Design: Possibilities for Industrial Use, Oxford (UK): BIOS Scientific Publishers, 1996, pp. 47–56.Google Scholar
  17. 17.
    Filimonov, D.A., Poroikov, V.V., Gloriozova, T.A., and Lagunin, A.A., Svidetel’stvo ob ofitsial’noi registratsii programmy dlya EVM PASS no. 2006613275, 15 sentyabrya 2006 (Certificate of official registration of the computer program PASS no. 2006613275 dated September 15 2006), Moscow: Federal Service for Intellectual Property, Patents and Trademarks, 2006.Google Scholar
  18. 18.
    Filimonov, D.A. and Poroikov, V.V., in Chemoinformatics Approaches to Virtual Screening, Varnek. A. and Tropsha, A., Eds., Cambridge (UK): RSC Publishing, 2008, pp. 182–216.Google Scholar
  19. 19.
    Filimonov, D.A., Lagunin, A.A., Gloriozova, T.A., Rudik, A.V., Druzhilovskii, D.S., Pogodin, P.V., and Poroikov, V.V., Khimiya geterotsiklicheskikh soedinenii, 2014, no. 3, pp. 483–499.Google Scholar
  20. 20.
    Poroikov, V., Lagunin, A., and Filimonov, D., in QSAR and Molecular Modelling in Rational Design of Bioactive Molecules, Esin, A.S. and Ismail, Y., Eds., Ankara: CADD A D Society, 2005, pp. 514–515.Google Scholar
  21. 21.
    Lagunin, A.A., Poroikov, V.V., Filimonov, D.A., and Gloriozova, T.A., Svidetel’stvo ob ofitsial’noi registratsii programmy dlya EVM PASS PharmaExpert, no. 2006613590 16 oktyabyra 2006 (Certificate of official registration of the computer program PharmaExpert no. 2006613590 dated October 16 2006), Moscow: Federal Service for Intellectual Property, Patents and Trademarks, 2006.Google Scholar
  22. 22.
    Newman, D.J. and Cragg, G.M., J. Natur. Prod., 2007, vol. 70, pp. 461–477. doi 10.1021/np068054vCrossRefGoogle Scholar
  23. 23.
    Ehrman, T.M., Barlow, D.J., and Hylands, P.J., J. Chem. Inf. Mod., 2007, vol. 47, pp. 254–263. doi 10.1021/ci700155tCrossRefGoogle Scholar
  24. 24.
    Poroikov, V.V., Filimonov, D.A., Borodina, Yu., Lagunin, A.A., and Kos, A., J. Chem. Inform. Comput. Sci., 2000, vol. 40, pp. 1349–1355. doi 10.1021/ci000383kCrossRefGoogle Scholar
  25. 25.
    Dalby, A., Nourse, J.G., Hounshell, W.D., Gushurst, A.K.I., Grier, D.L., Leland, B.A., and Laufer, J., J. Chem. Inform. Model., 1992, vol. 32, pp. 244–255. doi 10.1021/ci00007a012.CrossRefGoogle Scholar
  26. 26.
    Lagunin, A., Filimonov, D.A., and Poroikov, V.V., Cur. Phar. Des., 2010, vol. 16, pp. 1703–1717. doi 10.2174/138161210791164063CrossRefGoogle Scholar
  27. 27.
    Zakharov, A. and Lagunin, A., in Application of Computational Techniques in Pharmacy and Medicine, Gorb, L., Kuz’min, V., and Muratov, E., Eds., Springer, 2014, pp. 325–367.Google Scholar
  28. 28.
    Viswanathan, M.V., Unnikrishnan, P.M., Komatsu, K., Fushimi, H., and Basnet, P., Ind. J. Tradit. Knowledge, 2003, vol. 2, pp. 159–169. doi 10.1016/S10436618(02)00283-9Google Scholar
  29. 29.
    Goel, A., Jhurani, S., and Aggarwal, B.B., Mol. Nutr. Food Res., 2008, vol. 52, pp. 1010–1030. doi 10.1002/mnfr.200700354.CrossRefGoogle Scholar
  30. 30.
    Barasch, A., Elad, S., Altman, A., and Damato, K., Support Care Cancer, 2006, vol. 14, pp. 528–532. doi 10.1007/s00520-006-0066-1CrossRefGoogle Scholar
  31. 31.
    Deters, M., Klabunde, T., Meyer, H., Resch, K., and Kaever, V., Planta Med., 2003, vol. 69, pp. 337–343. doi 10.1055/s-2003-38870CrossRefGoogle Scholar
  32. 32.
    Biswas, J., Sinha, D., Mukherjee, S., Roy, S., Siddiqi, M., and Roy, M., Hum. Exp. Toxicol., 2010, vol. 29, pp. 513–524. doi 10.1177/ 0960327109359020CrossRefGoogle Scholar
  33. 33.
    Ameye, L.G. and Chee, W.C.C., Arthritis Res. Ther., 2006, vol. 8, R127. doi 10.1186/ar2016Google Scholar
  34. 34.
    Itokawa, H., Shi, Q., Akiyama, T., MorrisNatschke, S.L., and Lee, K.-H., Chinese Medicine 2008, vol. 3, 11. doi 10.1186/1749-8546-3-11Google Scholar
  35. 35.
    Aravindan, N., Madhusoodhanan, R., Ahmad, S., Johnson, D., and Herman, T.S., Cancer Biol. Ther., 2008, vol. 7, pp. 569–576. doi 10.4161/cbt.7.4.5534CrossRefGoogle Scholar
  36. 36.
    Goel, R.K., Gawande, D., Lagunin, A., Randhawa, P., Mishra A., and Poroikov, V., Planta Medica, 2015, vol. 81, pp. 495–506. doi 10.1055/S-0035-1545884CrossRefGoogle Scholar
  37. 37.
    Han, D., Yamada, K., Senzaki, K., Xiong, H., Nawa, H., and Nabeshima, T., J. Neurochem., 2000, vol. 74, pp. 792–798. doi 10.1046/j.14714159.2000.740792xCrossRefGoogle Scholar
  38. 38.
    Ramamoorthy, R., Radhakrishnan, M., and Borah, M., Behav. Pharmacol., 2008, vol. 19, pp. 29–40. doi 10.1097/FBP.0b013e3282f3cfd4CrossRefGoogle Scholar
  39. 39.
    Rollinger, J.M., Schuster, D., Danzl, B., Schwaiger, S., Markt, P., Schmidtke, M., Gertsch, J., Raduner, S., Wolber, G., Langer, T., and Stuppner, H., Planta Medica, vol. 75, pp. 195–204. doi 10.1055/s-0028-1088397Google Scholar
  40. 40.
    Kurkin, V.A., Farmakognoziya (Pharmacognosy), Samara: Medical University, 2007.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2016

Authors and Affiliations

  • A. A. Lagunin
    • 1
    • 2
  • D. S. Druzhilovsky
    • 1
  • A. V. Rudik
    • 1
  • D. A. Filimonov
    • 1
  • D. Gawande
    • 3
  • K. Suresh
    • 3
  • R. Goel
    • 3
  • V. V. Poroikov
    • 1
    • 2
  1. 1.Institute of Biomedical Chemistry (IBMC)MoscowRussia
  2. 2.Pirogov Russian National Research Medical UniversityMoscowRussia
  3. 3.Department of Pharmaceutical Sciences and Drug ResearchPunjabi UniversityPatialaIndia

Personalised recommendations